{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:08:46Z","timestamp":1778728126509,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Oncology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s1470-2045(16)30510-1","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T22:00:19Z","timestamp":1476828019000},"page":"e510-e514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":173,"title":["Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards"],"prefix":"10.1016","volume":"17","author":[{"given":"Andrew","family":"Bottomley","sequence":"first","affiliation":[]},{"given":"Madeline","family":"Pe","sequence":"additional","affiliation":[]},{"given":"Jeff","family":"Sloan","sequence":"additional","affiliation":[]},{"given":"Ethan","family":"Basch","sequence":"additional","affiliation":[]},{"given":"Franck","family":"Bonnetain","sequence":"additional","affiliation":[]},{"given":"Melanie","family":"Calvert","sequence":"additional","affiliation":[]},{"given":"Alicyn","family":"Campbell","sequence":"additional","affiliation":[]},{"given":"Charles","family":"Cleeland","sequence":"additional","affiliation":[]},{"given":"Kim","family":"Cocks","sequence":"additional","affiliation":[]},{"given":"Laurence","family":"Collette","sequence":"additional","affiliation":[]},{"given":"Amylou C","family":"Dueck","sequence":"additional","affiliation":[]},{"given":"Nancy","family":"Devlin","sequence":"additional","affiliation":[]},{"given":"Hans-Henning","family":"Flechtner","sequence":"additional","affiliation":[]},{"given":"Carolyn","family":"Gotay","sequence":"additional","affiliation":[]},{"given":"Eva","family":"Greimel","sequence":"additional","affiliation":[]},{"given":"Ingolf","family":"Griebsch","sequence":"additional","affiliation":[]},{"given":"Mogens","family":"Groenvold","sequence":"additional","affiliation":[]},{"given":"Jean-Francois","family":"Hamel","sequence":"additional","affiliation":[]},{"given":"Madeleine","family":"King","sequence":"additional","affiliation":[]},{"given":"Paul G","family":"Kluetz","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Koller","sequence":"additional","affiliation":[]},{"given":"Daniel C","family":"Malone","sequence":"additional","affiliation":[]},{"given":"Francesca","family":"Martinelli","sequence":"additional","affiliation":[]},{"given":"Sandra A","family":"Mitchell","sequence":"additional","affiliation":[]},{"given":"Carol M","family":"Moinpour","sequence":"additional","affiliation":[]},{"given":"Jammbe","family":"Musoro","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"O\u2019Connor","sequence":"additional","affiliation":[]},{"given":"Kathy","family":"Oliver","sequence":"additional","affiliation":[]},{"given":"Elisabeth","family":"Piault-Louis","sequence":"additional","affiliation":[]},{"given":"Martine","family":"Piccart","sequence":"additional","affiliation":[]},{"given":"Francisco L","family":"Pimentel","sequence":"additional","affiliation":[]},{"given":"Chantal","family":"Quinten","sequence":"additional","affiliation":[]},{"given":"Jaap C","family":"Reijneveld","sequence":"additional","affiliation":[]},{"given":"Christoph","family":"Sch\u00fcrmann","sequence":"additional","affiliation":[]},{"given":"Ashley Wilder","family":"Smith","sequence":"additional","affiliation":[]},{"given":"Katherine M","family":"Soltys","sequence":"additional","affiliation":[]},{"given":"Martin J B","family":"Taphoorn","sequence":"additional","affiliation":[]},{"given":"Galina","family":"Velikova","sequence":"additional","affiliation":[]},{"given":"Corneel","family":"Coens","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1470-2045(16)30510-1_bib1","series-title":"Crossing the quality chasm: a new health system for the 21st century","year":"2001"},{"key":"10.1016\/S1470-2045(16)30510-1_bib2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jnci\/djq508","article-title":"Quality-of-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001\u20132009)","volume":"103","author":"Lemieux","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S1470-2045(16)30510-1_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cct.2015.04.004","article-title":"Inclusion of patient-reported outcome measures in registered clinical trials: evidence from ClinicalTrials.gov (2007\u20132013)","volume":"43","author":"Vodicka","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/S1470-2045(16)30510-1_bib5","series-title":"BEST (Biomarkers, EndpointS, and other Tools) Resource","year":"2016"},{"key":"10.1016\/S1470-2045(16)30510-1_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(13)62229-1","article-title":"How to increase value and reduce waste when research priorities are set","volume":"383","author":"Chalmers","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S1470-2045(16)30510-1_bib9","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/annonc\/mdv249","article-title":"A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)","volume":"26","author":"Cherny","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/S1470-2045(16)30510-1_bib10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11136-010-9606-8","article-title":"The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study","volume":"19","author":"Mokkink","year":"2010","journal-title":"Qual Life Res"},{"key":"10.1016\/S1470-2045(16)30510-1_bib11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMp1511701","article-title":"Standardizing patient outcomes measurement","volume":"374","author":"Porter","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S1470-2045(16)30510-1_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1745-6215-15-279","article-title":"The COMET Initiative database: progress and activities from 2011 to 2013","volume":"15","author":"Gargon","year":"2014","journal-title":"Trials"},{"key":"10.1016\/S1470-2045(16)30510-1_bib13","doi-asserted-by":"crossref","first-page":"e110229","DOI":"10.1371\/journal.pone.0110229","article-title":"Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols","volume":"9","author":"Kyte","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S1470-2045(16)30510-1_bib14","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0140-6736(15)60599-2","article-title":"Putting patients at the heart of health-care research","volume":"385","author":"Calvert","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S1470-2045(16)30510-1_bib15","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient-reported outcomes in randomized trials","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S1470-2045(16)30510-1_bib16","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s11136-012-0252-1","article-title":"Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards","volume":"22","author":"Brundage","year":"2013","journal-title":"Qual Life Res"},{"key":"10.1016\/S1470-2045(16)30510-1_bib17","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/cncr.28935","article-title":"Bevacizumab and glioblastoma: scientific review, newly reported updates, and ongoing controversies","volume":"121","author":"Field","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/S1470-2045(16)30510-1_bib18","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/cncr.28010","article-title":"Health\u2013related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO\u20132 trial","volume":"119","author":"Burris","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/S1470-2045(16)30510-1_bib19","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1185\/03007995.2013.836078","article-title":"Health-related quality of life and disease symptoms in postmenopausal women with HR(+), HER2(\u2212) advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy","volume":"29","author":"Campone","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/S1470-2045(16)30510-1_bib21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJMp0911494","article-title":"the missing voice of patients in drug-safety reporting","volume":"362","author":"Basch","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S1470-2045(16)30510-1_bib22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/0962280213476378","article-title":"Practical and statistical issues in missing data for longitudinal patient-reported outcomes","volume":"23","author":"Bell","year":"2014","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/S1470-2045(16)30510-1_bib23","series-title":"Quality of life: the assessment, analysis and interpretation of patient-reported outcomes","author":"Fayers","year":"2013"},{"key":"10.1016\/S1470-2045(16)30510-1_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12885-016-2152-1","article-title":"Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review","volume":"16","author":"Fiteni","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/S1470-2045(16)30510-1_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.2014.56.7974","article-title":"Statistical challenges in the analysis of health-related quality of life in cancer clinical trials","volume":"34","author":"Bonnetain","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(16)30510-1_bib26","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s11136-015-1206-1","article-title":"The current practice of handling and reporting missing outcome data in eight widely used PROMs in RCT publications: a review of the current literature","volume":"7","author":"Rombach","year":"2016","journal-title":"Qual Life Res"}],"container-title":["The Lancet Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470204516305101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470204516305101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:16:56Z","timestamp":1761459416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470204516305101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1470204516305101"],"URL":"https:\/\/doi.org\/10.1016\/s1470-2045(16)30510-1","relation":{},"ISSN":["1470-2045"],"issn-type":[{"value":"1470-2045","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards","name":"articletitle","label":"Article Title"},{"value":"The Lancet Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1470-2045(16)30510-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}